Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for MCHC 39.9, Red 16.1, Platelet 527

  • Single Most Likely Diagnosis

    • Primary Thrombocythemia: This condition is characterized by an elevated platelet count, which is seen in this patient (Platelet 527). The increased red blood cell count (Red 16.1) could also be consistent with a myeloproliferative neoplasm, of which primary thrombocythemia is a type. The MCHC (Mean Corpuscular Hemoglobin Concentration) of 39.9 is within the normal range, which does not specifically point towards anemia but is consistent with the diagnosis of a myeloproliferative disorder.
  • Other Likely Diagnoses

    • Polycythemia Vera: Another myeloproliferative neoplasm that could explain the elevated red blood cell count and platelet count. The normal MCHC value does not contradict this diagnosis.
    • Reactive Thrombocytosis: This condition involves an elevated platelet count in response to another underlying condition, such as inflammation, infection, or iron deficiency anemia. However, the elevated red blood cell count is less typical for reactive thrombocytosis, making primary thrombocythemia or polycythemia vera more likely.
  • Do Not Miss Diagnoses

    • Essential Thrombocythemia with Early Myelofibrosis: Although less common, myelofibrosis can present with thrombocytosis and sometimes an increase in red blood cell mass. It's crucial to distinguish this from other myeloproliferative neoplasms due to differences in management and prognosis.
    • Chronic Myeloid Leukemia (CML): CML can present with an elevated platelet count and sometimes an increased red blood cell count. It's a critical diagnosis not to miss due to the availability of targeted therapies.
  • Rare Diagnoses

    • Hereditary Thrombocythemia: A rare condition caused by mutations in the thrombopoietin or its receptor, leading to elevated platelet counts. It's less likely but should be considered in the absence of other explanatory factors.
    • Other Myeloproliferative Neoplasms: Including chronic neutrophilic leukemia, chronic eosinophilic leukemia, and mastocytosis, which can occasionally present with thrombocytosis and changes in red blood cell counts. These are rare and would require specific diagnostic criteria to be met.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.